VanEck Biotech ETF
BBH
BBH
120 hedge funds and large institutions have $156M invested in VanEck Biotech ETF in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3% more ownership
Funds ownership: 28.43% → 31.43% (+3%)
Holders
120
Holding in Top 10
1
Calls
$432K
Puts
–
Top Buyers
| 1 | +$3.23M | |
| 2 | +$2.65M | |
| 3 | +$2.47M | |
| 4 |
Goldman Sachs
New York
|
+$2.04M |
| 5 |
Morgan Stanley
New York
|
+$1.96M |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$831K | |
| 3 | -$657K | |
| 4 |
TIA
Traphagen Investment Advisors
Oradell,
New Jersey
|
-$588K |
| 5 |
WEG
World Equity Group
Schaumburg,
Illinois
|
-$282K |